Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participants

Role of PD-L1 expression to guide immunotherapies in previously treated advanced NSCLC remains unclear and there is a lack of data comparing immune checkpoint inhibitors (ICIs) with each other. This network meta-analysis (NMA) aims to compare survival with ICIs to docetaxel and perform indirect comp...

Descrizione completa

Dettagli Bibliografici
Autori principali: Tan, P, Aguiar, P, Haaland, B, Lopes, G
Natura: Journal article
Lingua:English
Pubblicazione: Elsevier 2017